PDT Partners’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

PDT Partners’s Portfolio JNP Stock Details JNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-19,000	Closed	-$224K	–	1167
2015 Q3	$224K	Buy	19,000 +3,600	+23%	+$39.8K	0.01%	1121
2015 Q2	$141K	Buy	+15,400	New	+$116K	﹤0.01%	1280
2014 Q4	–	Sell	-10,200	Closed	-$60K	–	1264
2014 Q3	$60K	Sell	10,200 -3,500	-26%	-$21.3K	﹤0.01%	1252
2014 Q2	$94K	Buy	+13,700	New	+$91.7K	﹤0.01%	1367

Other funds holding JNP

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

PDT Partners's JNP Position: Q4 2015 in Review

PDT Partners sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q4 2015, closing a stake of 19,000 shares — an estimated $224K sold.

PDT Partners first reported a position in JNP in Q2 2014 and held it in 4 quarters. The position peaked at $224K in Q3 2015. 54 funds tracked by Wall St. Rank hold JNP as of Q4 2015.

PDT Partners reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
PDT Partners sold 19,000 Juniper Pharmaceuticals, Inc. Common Stock shares in Q4 2015, an estimated $224K.
PDT Partners first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2014 and held it in 4 quarters.
PDT Partners's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $224K in Q3 2015.
54 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2015.

Based on PDT Partners's 13F filing for Q4 2015, filed 16 Feb 2016.